Dexamethasone 8 MG: Clinical Trials

9 trials of Dexamethasone 8 MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 withdrawn, 1 active not recruiting, 1 not yet recruiting. 3 Not applicable, 3 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Withdrawn 2, Completed 1
Phase 43Completed 2, Not yet recruiting 1
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1
Phase 31Completed 1

Follow Dexamethasone 8 MG: new trials by email Literature Review of Dexamethasone 8 MG trials Research Report on Dexamethasone 8 MG

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Dependent Steroid Injections
Triamcinolone 10 Mg/mL Injectable Suspension, Triamcinolone 40 Mg/mL Injectable Suspension, Triamcinolone 80 Mg/mL Injectable Suspension - Lumbar Radiculopathy, Sciatica
Phase 4Not yet recruitingUniversity of Miami1502026-09-152026-08-12
Effect of Adding Dexamethasone to Bupivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Blocks Versus Bupivacaine Alone for Upper Limb Orthopaedic Surgery
Dexamethasone 8 mg - Dexamethasone, Bupivacaine
CompletedArsi University542024-01-012026-02-10
Multi-Strategy Intervention for Anesthesia Care of Obese Patients A Factorial Randomized Controlled Trial
Dexamethasone 8 mg, Applied inspiratory pressure (10, 15, 20, or 25 cmH2O), Tracheal intubation using video intubating stylet, video laryngoscopy, or direct laryngoscopy - Obesity, Bariatric Surgery Candidate
Not applicableWithdrawnYingHsuanTai2022-05-012022-05-24
Dexamethasone Versus Dexmedetomidine
dexamethasone 8 mg, dexmedetomidine 80 µg, Bupivacaine 0.25% Injectable Solution - Postoperative Pain
Phase 4CompletedFayoum University Hospital542017-03-082018-06-06
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Pembrolizumab 200 mg, Olaparib 400 mg, Docetaxel 75 mg/m^2 - Metastatic Castration-Resistant Prostate Cancer
Phase 1 / Phase 2Active not recruitingMerck Sharp & Dohme LLC12002016-11-172026-07-13
Comparison Between Dexamethasone and Morphine as an Adjuvant to Bupivacaine for Post-operative Analgesia
Dexamethasone 8 mg, Morphine 2 mg - Lower Extremities Fracture
Not applicableCompletedUniversitas Indonesia642016-05-012017-08-18
TRARO (Traumeel® S in Rotator Cuff Syndrome)-Study
Traumeel S inj, Fortecortin/Dexamethasone 8 mg/2 ml inj, Saline inj - Rotator Cuff Syndrome, Shoulder Bursitis
Phase 3CompletedBiologische Heilmittel Heel GmbH1752013-04-012016-02-24
Trial Comparing Duration of Analgesia After Popliteal Fossa Sciatiac Nerve Block With Ropivacaine 0.5% When Combined With Placebo, Dexamethasone 4mg or Dexamethasone 8 mg
Placebo, Dexamethasone 4 mg, Dexamethasone 8 mg - Pain, Sciatic Block
Not applicableWithdrawnBaylor College of Medicine2012-07-012015-03-17
Effect of Low-Dose Dexamethasone on the Incidence of Hyperglycemia Following Surgery
Control-saline, Dexamethasone 4 mg, Dexamethasone 8 mg - Postoperative Complications
Phase 4CompletedEndeavor Health2002009-09-012019-09-30

Conditions studied

Back Pain (1)  ·  Gastroesophageal Reflux (1)  ·  Hyperglycemia (1)  ·  Obesity (1)  ·  Pain (1)  ·  Pain, Postoperative (1)  ·  Postoperative Complications (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Radiculopathy (1)  ·  Sciatica (1)

Sponsors

Arsi University (1)  ·  Baylor College of Medicine (1)  ·  Biologische Heilmittel Heel GmbH (1)  ·  Endeavor Health (1)  ·  Fayoum University Hospital (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Universitas Indonesia (1)  ·  University of Miami (1)  ·  YingHsuanTai (1)

Countries

United States (3)  ·  Belgium (1)  ·  Egypt (1)  ·  Ethiopia (1)  ·  Indonesia (1)  ·  Taiwan (1)

Top investigators

Aida R Tantri, PhD (1)  ·  Glenn S Murphy, MD (1)  ·  Hany M Yassin, MD (1)  ·  Luc Vandenbossche, MD, PhD (1)  ·  Ying-Hsuan Tai, M.D. (1)

Results publications

PMID 25649543, PMID 35397952, PMID 37940446, PMID 38926066, PMID 40796417, PMID 42070919

NIH funding

2016 (1), 2023 (1)